Most Popular
-
1
Exports to US reach all-time high, widen gap with China
-
2
Trump rekindles criticism: US forces defending 'wealthy' S. Korea 'free of charge'
-
3
[Music in drama] Rekindle a love that slipped through your fingers
-
4
S. Korea discussed possible participation in AUKUS Pillar 2 with Australia: defense minister
-
5
[New faces of Assembly] Architect behind ‘audacious initiative’ believes in denuclearized North Korea
-
6
Seoul Metro to seek legal action against malicious complaints
-
7
On May Day, labor unions blast Yoon's foreign nanny proposal
-
8
Illit, mired in controversy, remains on Billboard charts for 5th week
-
9
Opposition-led Assembly unilaterally passes bill to probe Marine's death
-
10
[KH Explains] Will alternative trading platform shake up Korean stock market?
-
Excelra Makes Strategic Investment in Anlitiks, a Disruptive HEOR and RWE Technology-led Consulting Company
HYDERABAD, India and BOSTON, Mass., April 19, 2022 /PRNewswire/ -- Excelra, a leading global Data and Analytics provider for Life Science organizations, has announced a strategic majority investment in Anlitiks, a young and rapidly growing technology company in the value and evidence domain. The investment reinforces Excelra's push into the Health Economics and Outcomes Research (HEOR) and Real-World Evidence (RWE) analytics area. This deal is a testimony to Excelra's commitment to drug
April 19, 2022
-
TopOn Moves Into In-App Bidding Open Beta on Meta Audience Network
GUANGZHOU, China, April 19, 2022 /PRNewswire/ -- We are happy to announce that TopOn has moved out of closed beta and is now an official open beta bidding partner with Meta Audience Network! By making bidding with Meta Audience Network more widely available, the integration is now available for all publishers to join Meta Audience Network's bidding system immediately without manual approval, making it quicker and easier to experience the full benefits of in-app bidding. jwplaye
April 19, 2022
-
Zoomlion Releases World's First Hybrid All-terrain Crane, Driving Industry's New Energy Revolution
CHANGSHA, China, April 19, 2022 /PRNewswire/ -- Zoomlion Heavy Industry Science & Technology Co., Ltd. ("Zoomlion"; 1157.HK) has released the world's first hybrid all-terrain crane ZAT2200VE863 on April 11, marking another innovative milestone following the previous release of the world's first pure electric crane. With superior hybrid output performance, the ZAT2200VE863 has achieved the advantage of a dual electric and fuel power system and driven by a gasoline-electric du
April 19, 2022
-
Quali Strengthens Infrastructure Control Plane Features for DevOps and IT Teams with Latest Release of Torque
New features enhance automation and orchestration capabilities, improve cost controls, and strengthen security postures AUSTIN, Texas, April 19, 2022 /PRNewswire/ -- Ahead of AWS Summit in San Francisco Quali, a leading provider of Environments-as-a-Service infrastructure automation solutions, announced the release of enhanced control plane features for its Torque platform, which enables DevOps professionals to orchestrate and secure complex application environments
April 19, 2022
-
JCET Group Subsidiary Recognized for Excellence by Texas Instruments
SHANGHAI, April 19, 2022 /PRNewswire/ -- Jiangyin Changdian Advanced Packaging Co., LTD. (JCAP), a subsidiary of JCET Group, has received the Texas Instruments (TI) 2021 Supplier Excellence Award. This is the sixth time that JCAP has won this award for its excellence in integrated circuit product manufacturing and technical service capabilities. The "TI Supplier Excellence Award" is the highest TI award issued to their best performing global suppliers. JCAP is an important par
April 19, 2022
-
Novavax Announces Approval of Nuvaxovid™ COVID-19 Vaccine for Primary and Booster Immunization in Japan
Nuvaxovid is the first protein-based COVID-19 vaccine approved for use in adults aged 18 and older in Japan Approval is first in the world for NVX-CoV2373 that includes both primary and booster vaccination GAITHERSBURG, Md., April 19, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that its partner, Takeda, received manufacturi
April 19, 2022
-
Gastroenterology: NTC submits marketing authorisation application for KLEERKOL® in EU
MILAN, April 19, 2022 /PRNewswire/ -- NTC Srl, R&D driven pharmaceutical company with headquarters in Italy announces the submission of the marketing authorisation application through the European Decentralised Procedure (DCP) for its development product NTC015 (Kleerkol®) for bowel preparation for colonoscopy. "Colonoscopy remains the standard for diagnosing and monitoring colorectal cancer and for diagnosis and surveillance of inflammatory bowel disease", says Maurizio Vecc
April 19, 2022
-
Tencent Cloud Introduces Lighthouse Server Services for SMEs, Developers
Easy-to-use and cost-effective cloud server services with out-of-the-box features for lightweight business scenarios SME Booster Program launched to provide up to USD500 exclusive rebate packages and various product free trials to SMEs HONG KONG, April 19, 2022 /PRNewswire/ -- More and more businesses are seeing the benefits of cloud usage, with a scale going beyond large corporations and reaching more small and medium-sized enterprises (SMEs) in recent years. Furthermore, ind
April 19, 2022
-
Pondok Indah Hospital Group first in Indonesia to achieve HIMSS EMRAM Stage 6
JAKARTA, Indonesia, April 19, 2022 /PRNewswire/ -- HIMSS announced today that Pondok Indah Hospital Group has become the first healthcare provider in Indonesia to achieve Stage 6 on the HIMSS Electronic Medical Record Adoption Model (EMRAM). The eight-stage EMRAM measures clinical outcomes, patient engagement and clinician use of electronic medical record technology to strengthen organisational performance and health outcomes across patient populations. All three hospitals operated by the hosp
April 19, 2022
-
Translumina launches VIVO ISAR, its Dual-Drug Polymer-free Coated Stent (DDCS) in International markets
Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey NEW DELHI and HECHINGEN, Germany, April 19, 2022 /PRNewswire/ -- Translumina, a global developer and manufacturer of innovative cardiovascular medical devices used in interventional cardiology, announces the launch of VIVO ISAR, its latest generation dual drug polymer-free coated stent (DDCS), in various International mar
April 19, 2022
-
Toshiba Wins Two Awards at iF DESIGN AWARD 2022
TOKYO, April 19, 2022 /PRNewswire/ -- Toshiba Corporation (TOKYO: 6502) has reconfirmed its commitment to quality and excellence in design by clinching two awards at iF DESIGN AWARD 2022. The award-winning projects are Toshiba Quantum Key Distribution System, a secure key distribution system, in the product design discipline; and Toshiba co-creation center Creative Circuit, a co-creation space, in the interior architecture discipline. iF DESIGN AWARD, one of the most prestigiou
April 19, 2022
-
131st Canton Fair buyer story: Bekar Mikaberidze - bridging the trade between China and Georgia
GUANGZHOU, China, April 19, 2022 /PRNewswire/ -- The 131st Canton Fair has hosted another "Trade Bridge" event on April 14 to connect Tbilisi of Georgia and Guangzhou. The Fair also signed a global partnership with Georgia via an online signing ceremony and arranged a special event for Georgian wine companies. Georgia is known as the hometown and place of origin of the wine. With more than 8,000 years of winemaking tradition, the country is the oldest winemaking country in the w
April 19, 2022
-
PEI-Genesis Set up its Japan office to Continuously Strengthen its Footprint in Asia-Pacific Market
TOKYO, April 19, 2022 /PRNewswire/ -- PEI-Genesis is extremely excited to announce the appointment of Shoko Kuri as the Country Manager, Japan effective February 14th. Shoko-san based in Tokyo is PEI's first employee in Japan. Shoko-san reports to David Lee, Sales Director of North Asia. Shoko-san has come to the PEI family with close to 20 years in connector sales and marketing experience covering a wide range of customers, applications, channel partners and suppliers in Japan. Her
April 19, 2022
-
MENTAL METAVERSE - TAGO LEADS THE WORLD IN APPLYING BLOCKCHAIN IN MENTAL HEALTH CARE
HO CHI MINH CITY, Vietnam, April 19, 2022 /PRNewswire/ -- TAGO, a UK-registered tech startup aims to connect the people who are in need of mental help with the appropriate support within an application. User can now receive consultation from the best available mental advisors with just a click. By applying blockchain technology, Tago will helps users have double benefits. They can find the solution for their mental health problems, and earn tokens through the "Talk to Earn" activi
April 19, 2022
-
ZOLOZ listed as a Representative Vendor in 2022 Gartner® Market Guide for Identity Proofing and Affirmation
BEIJING, April 19, 2022 /PRNewswire/ -- ZOLOZ, a global leading technology service provider of AI-powered Digital Identity Verification Solution, has been mentioned as a Representative Vendor in the latest Gartner Market Guide for Identity Proofing and Affirmation, published on March 2, 2022. "The listed vendors represent what's core in the market, what extends it and what will transform it," stated the Market Guide. According to the Market Guide report, "Identity-
April 19, 2022
-
Proprietary SARS-CoV-2 3CL Inhibitor Rapidly Progressing in Clinical Trials, Market Approval of Trilaciclib Expected in China, Simcere Reveals Global Innovation Ambition on R&D Day
NANJING, China, April 19, 2022 /PRNewswire/ -- On April 15, 2022, Simcere Pharmaceutical (2096.HK), an innovation and R&D driven pharmaceutical company in China held its first R&D day for international investors, during which the executive leaders revealed Simere's R&D strategy, and gave an update on Simcere's pipeline to the global investment community. Mr. REN Jinsheng, Chairman and CEO, Dr. TANG Renhong, Executive Vice President, Dr. Bijoyesh Mookerjee, Chief Medical Office
April 19, 2022
-
MGI announces partnership with Nalagenetics to advance personalized medicine
The partnership will address some critical issues in pharmacogenetic assay through sequencing workflows improvement SINGAPORE, April 19, 2022 /PRNewswire/ -- MGI, a company committed to being a world-leading life science innovator, today announced a partnership with Nalagenetics (NALA) to co-develop low coverage whole genome sequencing for risk prediction and population genomics through optimizing Next Generation Sequencing (NGS) workflow based on MGI sequencing devices and products*.
April 19, 2022
-
Bridge Biotherapeutics Enters into an Exclusive License Agreement with Shaperon to Strengthen Its IPF Franchise
The licensing deal includes an upfront payment of USD 1.63 million, and may reach up to USD 24.4 million in milestone payments and royalties By strengthening the company's fibrotic disease development pipeline, Bridge will enhance its strategic focus on the development of comprehensive treatment solutions for idiopathic pulmonary fibrosis (IPF) SEONGNAM, South Korea, April 19, 2022 /PRNewswire/ -- Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotechnology company
April 19, 2022
-
utu Partners Up with EVA AIR Infinity MileageLands to Provide More VAT Rewards for Travelers
The addition of the EVA Air Frequent Flyer Programme bolsters the platform's already impressive offerings SINGAPORE, April 19, 2022 /PRNewswire/ -- Singapore-based travel technology company utu announced today its new partnership with Infinity MileageLands, the frequent-flyer programme of Taiwan's EVA Air. The agreement allows utu to continue to revolutionize the travel industry in the area of international tax-free shopping and VAT rewards for customers that travel often.
April 19, 2022
-
Prioritizing Quality and Patient Satisfaction, Pondok Indah Hospital Group Achieves HIMSS EMRAM Stage 6, the First in Indonesia
JAKARTA, Indonesia, April 19, 2022 /PRNewswire/ -- Pondok Indah Hospital Group (Rumah Sakit Pondok Indah Group) continues to carry out digital transformation through optimization, efficiency, and continuous integration efforts, consistent with the hospital group commitment to providing the best health services by prioritizing quality, security, safety, and comfort for patients. This digital transformation is also in line with the Indonesian government's efforts to encourage digitalization in the
April 19, 2022